Clinical findings: Fucoidan relieves prostate symptoms
A clinical trial has shown that high purity Undaria pinnatifida fucoidan supplementation relieved the symptoms of benign prostatic hyperplasia (BPH).
A clinical trial has shown that high purity Undaria pinnatifida fucoidan supplementation relieved the symptoms of benign prostatic hyperplasia (BPH).
Researchers suggested that fucoidans exert a protective effect during infection and therefore they may be promising candidates against L. monocytogenes. Read more
Marinova will be attending the Asia Healthcare & Medical Cosmetology Expo, part of BIO Asia-Taiwan in Taipei from July 16-19. Read more
Recently published research has introduced FINAL (Fucoidan-docetaxel Immunomodulatory Nanoparticles as an Antitumoral Lancer), an innovative nanoplatform with the potential to address multiple cancer types. Read more
Marinova welcomes Meegan Grubb to the position of Analytical Chemist. Read more